H.R. 3747

119th Congress

In Committee

Accelerating Access to Dementia and Alzheimer’s Provider Training Act

Sponsored byRepublican:Rep. Balderson, Troy [R-OH-12]OH· Introduced 5 juin 2025

97

Cosponsors

18

Actions

0

Amendments

1

Committees

Since introduced

Introduced
Committee
Passed Chamber
Passed Both
Enacted
Step 1 of 0
Latest action

Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

21 juillet 2026·2 days ago

Summary

Reported to House · Updated 16 juillet 2026

Accelerating Access to Dementia and Alzheimer’s Provider Training Act or the AADAPT Act

This bill reauthorizes through FY2031 and revises the Technology-enabled Collaborative Learning Program, which is administered by the Health Resources and Services Administration. This program provides grants to support the use of technology that connects different health care professionals to improve access to health care, including specialty care, for certain rural and medically underserved populations. 

The bill explicitly adds dementia care to the types of specialty care that the program may address.

Timeline

18 actions

  1. Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

    21 juillet 2026 · IntroReferral

  2. DEBATE - The House proceeded with forty minutes of debate on H.R. 3747.

    20 juillet 2026 · Floor

  3. Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.

    20 juillet 2026 · Floor

  4. On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.

    20 juillet 2026 · Floor

  5. Motion to reconsider laid on the table Agreed to without objection.

    20 juillet 2026 · Floor

  6. Mr. Guthrie moved to suspend the rules and pass the bill, as amended.

    20 juillet 2026 · Floor

  7. Considered under suspension of the rules.

    20 juillet 2026 · Floor

  8. Mr. Guthrie moved to suspend the rules and pass the bill, as amended.

    20 juillet 2026 · Floor

  9. Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-723.

    2 juillet 2026 · Committee

  10. Placed on the Union Calendar, Calendar No. 628.

    2 juillet 2026 · Calendars

  11. Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-723.

    2 juillet 2026 · Committee

  12. Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-723.

    2 juillet 2026 · Committee

  13. Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-723.

    2 juillet 2026 · Committee

  14. Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-723.

    2 juillet 2026 · Committee

  15. Placed on the Union Calendar, Calendar No. 628.

    2 juillet 2026 · Calendars

  16. Committee Consideration and Mark-up Session Held

    21 mai 2026 · Committee

  17. Committee Consideration and Mark-up Session Held

    21 mai 2026 · Committee

  18. Committee Consideration and Mark-up Session Held

    21 mai 2026 · Committee

  19. Committee Consideration and Mark-up Session Held

    21 mai 2026 · Committee

  20. Ordered to be Reported by the Yeas and Nays: 48 - 0.

    21 mai 2026 · Committee

Sponsorship

97 cosponsors

Sponsor

Republican:Rep. Balderson, Troy [R-OH-12]OH

Cosponsors

  • Democrat3876%
  • Republican1224%

Classification

Policy area

Health

Legislative subjects

Congressional oversightGovernment information and archivesHealth programs administration and fundingHealth technology, devices, suppliesMedical tests and diagnostic methodsNeurological disorders

Committees

1

  • Energy and Commerce Committee

    House · Standing

    • Referred To5 Jun 2025
    • Markup By21 May 2026
    • Health Subcommittee

      • Referred to5 Jun 2025
      • Markup by13 May 2026
      • Reported by13 May 2026
Pelosi Tracker
© 2026 - Tous droits réservés. Propulsé par Vantara Labs
Ce site web est une plateforme indépendante et tierce. Il n'est pas affilié à, approuvé par ou associé de quelque manière que ce soit à Nancy Pelosi, son bureau ou ses représentants. Toute utilisation de son nom est uniquement à des fins de discussion d'informations publiques disponibles.Les informations fournies sur ce site web sont uniquement à des fins informatives et éducatives et ne sont pas destinées à servir de conseils financiers ou d'investissement, ni ne doivent être interprétées comme tels. Les données présentées ici proviennent de déclarations et dossiers publics. Bien que nous nous efforcions d'assurer l'exactitude, l'actualité et l'exhaustivité, nous ne garantissons pas que toutes les informations sont exemptes d'erreurs ou à jour.Le support est disponible en anglais. Certaines traductions sont automatiques.